A critical evaluation of drug interactions with Echinacea spp.

Molecular Nutrition and Food Research

Volumn 52, Issue 7, 2008, Pages 789-798

  Freeman, Camille ^a,c   Spelman, Kevin ^b,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^c Tai Sophia Institute   (United States)

Author keywords

Angustifolia; CYP 450; Echinacea; Pallida; Purpurea

Indexed keywords

ECHINACEA ANGUSTIFOLIA; ECHINACEA PALLIDA; ECHINACEA PURPUREA;

CYTOCHROME P450; GLYCOPROTEIN P;

DRUG EFFECT; DRUG INTERACTION; ECHINACEA; HERB DRUG INTERACTION; HUMAN; MEDICINAL PLANT; METABOLISM; REVIEW;

CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ECHINACEA; HERB-DRUG INTERACTIONS; HUMANS; P-GLYCOPROTEIN; PLANTS, MEDICINAL;

EID: 53249152208     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700113     Document Type: Review

References (78)

1. Nelson, L., Perrone, J., Herbal and alternative medicine. Emerg. Med. Clin. North Am. 2000, 18, 709-722.
2. Kaiser Family Foundation, Prescription Drug Trends, The Henry J. Kaiser Family Foundation, Washington, DC 2006, pp. 1-5.
3. Slone Epidemiology Center, Patterns of Medication Use in the United States, 2004: A Report from the Slone Survey, Slone Epidemiology Center at Boston University, Boston 2004.
4. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., et al., Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. Jama 1998, 280, 1569-1575.
5. Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., Mitchell, A. A., Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. Jama 2002, 287, 337-344.
6. Blumenthal, M., Ferrier, G. K. L., Cavaliere, C., Total sales of herbal supplements in United States show steady growth. HerbalGram 2006, 71, 64-66.
7. SPINS Inc. Schaumburg, Echinacea Sales Report, 2007.
8. King, J., Felter, H. W., Lloyd, J. U., King's American dispensatory, Ohio Valley Co., Cincinnati 1898.
9. Felter, H. W., The Eclectic Materia Medica, Pharmacology and Therapeutics, J. K. Scudder, Cincinnati 1922.
10. Barrett, B., Medicinal properties of echinacea: A critical review. Phytomedicine 2003, 10, 66-86.
11. Blumenthal, M., Busse, W. R., Bundesinstitut fèur Arzneimittel und Medizinprodukte (Germany), The Complete German Commission E monographs, Therapeutic Guide to Herbal Medicines, American Botanical Council, Integrative Medicine Communications, Austin, Texas, Boston 1998, pp. xxii, 685.
12. Bauer, R., Echinacea drugs-effects and active ingredients. Z. Arztl. Fortbild. 1996, 90, 111-115.
13. Chen, Y., Fu, T., Tao, T., Yang, J., et al., Macrophage activating effects of new alkamides from the roots of Echinacea species. J. Nat. Prod. 2005, 68, 773-776.
14. Hudson, J., Vimalanathan, S., Kang, L., Amiguet, V. T., et al., Characterization of antiviral activities in echinacea root preparations. Pharm. Biol. 2005, 43, 790-796.
15. Li, T. S. C., Echinacea: Cultivation and medicinal value. Horttechnology 1998, 8, 122-129.
16. Bauer, R., Foster, S., Analysis of alkamides and caffeic acid derivatives from Echinacea simulata and E. paradoxa roots. Planta Med. 1991, 57, 447-449.
17. Williamson, E., Interactions between herbal and conventional medicines: The role of cytochrome P450 enzymes and P-glycoprotein. Pharmacologyonline 2006, 2, 200-205.
18. Mills, S., Bone, K., Principles and Practice of Phytotherapy, Churchill Livingstone, Edinburgh 2000.
19. Messina, B. A. M., Herbal supplements: Facts and mythstalking to your patients about herbal supplements. J. Perianesth. Nurs. 2006, 21, 268.
20. Crowe, S., Lyons, B., Herbal medicine use by children presenting for ambulatory anesthesia and surgery. Paediatr. Anaesth. 2004, 14, 916-919.
21. Vickers, A., Zollman, C., ABC of complementary medicine: Herbal medicine. BMJ 1999, 319, 1050-1053.
22. Miller, L. G., Herbal medicinals - selected clinical considerations focusing on known or potential drug-herb interactions. Arch. Intern. Med. 1998, 158, 2200-2211.
23. Mengs, U., Clare, C. B., Poiley, J. A., Toxicity of Echinacea purpurea. Acute, subacute and genotoxicity studies. Arzneimittelforschung 1991, 41, 1076-1081.
24. Mills, S., Bone, K., The Essential Guide to Herbal Safety, Elsevier Churchill Livingston, St. Louis 2005.
25. Spelman, K., Herb drug interactions. Pharmacokinetic/pharmacodynamics, in: Yoshikawa, T. T., Norman, D. C. (Eds.), Acute Emergencies and Critical Care of the Geriatric Patient, M. Dekker, New York 2000, pp. xiv, 519.
26. Mattocks, A. R., Chemistry and Toxicology of Pyrrolizidine Alkaloids, Academic Press, London, Orlando, FL 1986, pp. x, 393.
27. Brazier, N. C., Levine, M. A., Drug-herb interaction among commonly used conventional medicines: A compendium for health care professionals. Am. J. Ther. 2003, 10, 163-169.
28. Coon, J. T., Herb-drug interactions: Survey of leading pharmaceutical/herbal companies. Arch. Intern. Med. 2003, 163, 1371.
29. Budzinski, J. W., Foster, B. C., Vandenhoek, S., Arnason, J. T., An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000, 7, 273-282.
30. Foster, B., Vandenhoek, S., Hana, J., Krantis, A., et al., In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 2003, 10, 334-342.
31. Yale, S. H., Glurich, I., Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J. Altern. Complement. Med. 2005, 11, 433-439.
32. Gorski, J. C., Huang, S. M., Pinto, A., Hamman, M. A., et al., The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin. Pharmacol. Ther. 2004, 75, 89-100.
33. Moulick, K., Raner, G., Effects of echinacea on human metabolizing systems, in 55th Southeast Regional Meeting of the American Chemical Society, American Chemical Society, Atlanta, GA 2003.
34. Raner, G., Cornelious, S., Moulick, K., Wang, Y., et al., Effects of herbal products and their constituents on human cytochrome P4502E1 activity. Food Chem. Toxicol. 2007, 45, 2359-2365.
35. Gurley, B. J., Gardner, S. F., Hubbard, M. A., Williams, D. K., et al., In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin. Pharmacol. Ther. 2004, 76, 428-440.
36. Fuchikami, H., Satoh, H., Tsujimoto, M., Ohdo, S., et al., Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab. Dispos. 2006, 34, 577-582.
37. Gilroy, C. M., Steiner, J. F., Byers, T., Shapiro, H., Georgian, W., Echinacea and truth in labeling. Arch. Intern. Med. 2003, 163, 699-704.
38. Nebert, D. W., Russell, D. W., Clinical importance of the cytochromes P450. Lancet 2002, 360, 1155-1162.
39. Stansbury, J., Repiratory - formulae. Med. Herbalism 1993, 5, 7-8.
40. Sharma, M., Arnason, J. T., Burt, A., Hudson, J. B., Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Phytother. Res. 2006, 20, 147-152.
41. Muller-Jakic, B., Breu, W., Probstle, A., Redl, K., et al., In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species. Planta Med. 1994, 60, 37-40.
42. Hinz, B., Woelkart, K., Bauer, R., Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells. Biochem. Biophys. Res. Commun. 2007, 360, 441-446.
43. Merali, S., Binns, S., Paulin-Levasseur, M., Ficker, C., et al., Antifungal and anti-inflammatory activity of the Genus Echinacea. Pharm. Biol. 2003, 41, 412-420.
44. Vimalanathan, S., Kang, L., Amiguet, V. T., Livesey, J., et al., Echinacea purpurea aerial parts contain multiple antiviral compounds. Pharm. Biol. 2005, 43, 740-745.
45. Gertsch, J., Raduner, S., Altmann, K. H., New natural non-cannabinoid ligands for cannabinoid type-2 (CB2) receptors. J. Recept. Signal Transduct. Res. 2006, 26, 709-730.
46. Gertsch, J., Schoop, R., Kuenzle, U., Suter, A., Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 2004, 577, 563-569.
47. Woelkart, K., Xu, W., Pei, Y., Makriyannis, A., et al., The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots. Planta Med. 2005, 71, 701-705.
48. Raduner, S., Majewska, A., Chen, J.-Z., Xie, X.-Q., et al., Alkylamides from Echinacea are a new class of cannabinomimetics: Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J. Biol. Chem. 2006, 281, 14192-14206.
49. Matovic, N., Matthias, A., Gertsch, J., Raduner, S., et al., Stereoselective synthesis, natural occurrence and CB2 receptor binding affinities of alkylamides from herbal medicines such as Echinacea sp. Org. Biomol. Chem. 2007, 5, 169-174.
50. Singh, J., Budhiraya, S., Therapeutic potential of cannabinoid receptor ligands: Current status. Methods Find Exp. Clin. Pharmacol. 2006, 28, 177-183.
51. Pertwee, R. G., Ross, R. A., Cannabinoid receptors and their ligands. Prostaglandins Leukot. Essent. Fatty Acids 2002, 66, 101.
52. Lunn, C. A., Fine, J. S., Rojas-Triana, A., Jackson, J. V., et al., A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo. J. Pharmacol. Exp. Ther. 2006, 316, 780-788.
53. Schoop, R., Klein, P., Suter, A., Johnston, S. L., Echinacea in the prevention of induced rhinovirus colds: A meta-analysis. Clin. Ther. 2006, 28, 174-83.
54. Mouly, S. J., Matheny, C., Paine, M. F., Smith, G., et al., Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5. Clin. Pharmacol. Ther. 2005, 78, 605-618.
55. Meijerman, I., Beijnen, J. H., Schellens, J. H. M., Herb-drug interactions in oncology: Focus on mechanisms of induction. Oncologist 2006, 11, 742-752.
56. Melchart, D., Linde, K., Worku, F., Sarkady, L., et al., Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea. J. Altern. Complement. Med. 1995, 1, 145-160.
57. Roesler, J., Emmendorffer, A., Steinmuller, C., Luettig, B., et al., Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system. Int. J. Immunopharmacol. 1991, 13, 931-941.
58. See, D. M., Broumand, N., Sahl, L., Tilles, J. G., et al., In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997, 35, 229-235.
59. Steinmuller, C., Roesler, J., Grottrup, E., Franke, G., et al., Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int. J. Immunopharmacol. 1993, 15, 605-614.
60. Gan, X. H., Zhang, L., Heber, D., Bonavida, B., Mechanism of activation of human peripheral blood NK cells at the single cell level by Echinaceawater soluble extracts: Recruitment of lymphocyte-target conjugates and killer cells and activation of programming for lysis. Int. Immunopharmacol. 2003, 3, 811-824.
61. Delorme, D., Miller, S. C., Dietary consumption of Echinacea by mice afflicted with autoimmune (type 1) diabetes: Effect of consuming the herb on hemopoietic and immune cell dynamics. Autoimmunity 2005, 38, 453-461.
62. Lersch, C., Zeuner, M., Bauer, A., Siebenrock, K., et al., Stimulation of the immune response in outpatients with hepatocellular carcinomas by low doses of cyclophosphamide (LDCY), echinacea purpurea extracts (Echinacin) and thymostimulin. Arch. Geschwulstforsch. 1990, 60, 379-383.
63. Currier, N. L., Miller, S. C., Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span. J. Altern. Complement. Med. 2001, 7, 241-251.
64. Chicca, A., Adinolfi, B., Martinotti, E., Fogli, S., et al., Cytotoxic effects of Echinacea root hexanic extracts on human cancer cell lines. J. Ethnopharmacol. 2007, 110, 148-153.
65. Melchart, D., Clemm, C., Weber, B., Draczynski, T., et al., Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy - a pilot study. Phytother. Res. 2002, 16, 138-142.
66. Currier, N. L., Miller, S. C., Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated. Exp. Gerontol. 2000, 35, 627-639.
67. Matthias, A., Gillam, E. M., Penman, K. G., Matovic, N. J., et al., Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes. Chem. Biol. Interact. 2005, 155, 62-70.
68. Halliwell, B., Oxidative stress in cell culture: An under-appreciated problem? FEBS Lett. 2003, 540, 3-6.
69. Cech, N. B., Tutor, K., Doty, B. A., Spelman, K., et al., Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: Production of novel metabolites and changes in immunomodulatory activity. Planta Med. 2006, 72, 1372-1377.
70. Woelkart, K., Bauer, R., New insights in the bioavailability and molecular mode of action of Echinacea preparations. Planta Med. 2006, 72, 982-983.
71. Modarai, M., Gertsch, J., Suter, A., Heinrich, M., Kortenkamp, A., Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. J. Pharm. Pharmacol. 2007, 59, 567-573.
72. Koley, A. P., Buters, J. T. M., Robinson, R. C., Markowitz, A., Friedman, F. K., Differential mechanisms of cytochrome P450 inhibition and activation by alpha-naphthoflavone. J. Biol. Chem. 1997, 272, 3149-3152.
73. Ioannides, C., Effect of diet and nutrition on the expression of cytochromes P450. Xenobiotica 1999, 29, 109-154.
74. Fugh-Berman, A., Ernst, E., Herb-drug interactions: Review and assessment of report reliability. Br. J. Clin. Pharmacol. 2001, 52, 587-595.
75. Izzo, A. A., Ernst, E., Interactions between herbal medicines and prescribed drugs - a systematic review. Drugs 2001, 61, 2163-2175.
76. Basch, E., Ulbricht, C., Basch, S., Dalton, S., et al., An evidence-based systemic review Echinacea E. angustifolia DC, E. pallida, E. purpurea by the Natural Standard Research Collaboration. J. Herb Pharmacother. 2005, 5, 57-88.
77. Dergal, J. M., Gold, J. L., Laxer, D. A., Lee, M. S. W., et al., Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging 2002, 19, 879-886.
78. Barrett, B., Echinacea; a safety review. HerbalGram 2003, 57, 36-39.